Literature DB >> 19324127

Prognostic variables in thoracic esophageal squamous cell carcinoma.

Chen-Sung Lin1, Shi-Chuan Chang, Yau-Huei Wei, Teh-Ying Chou, Yu-Chung Wu, Hui-Chen Lin, Liang-Shun Wang, Wen-Hu Hsu.   

Abstract

BACKGROUND: Thoracic esophageal squamous cell carcinoma (TESCC) is an aggressive malignancy with a poor prognosis. The current American Joint Committee on Cancer (AJCC) TNM cancer staging system focusing on the effect of regional (N1) and nonregional lymph node (M1a and M1b) metastasis may need reappraisal. We investigated the role of the number of dissected and positive nodes in TESCC patients.
METHODS: A total of 109 TESCC patients (97 men; mean age of 62.3 years) who underwent surgical resection were retrospectively analyzed. The current AJCC TNM system and other lymph node classifications were used to subgroup these patients and analyze survival differences. Previously reported prognostic factors were evaluated.
RESULTS: Patients with positive lymph node metastasis had a poor prognosis (p < 0.001). There was a significant difference in survival among the 67 node-positive patients subdivided into subgroups with 1 to 3 and 4 or more positive nodes (p = 0.004). Multivariable Cox proportional hazard regression analysis identified four independent prognostic factors: difficulty in swallowing (p = 0.024), cigarette smoking (p = 0.003), number of positive lymph nodes (0, 1 to 3, and > or = 4; p < 0.001), and gastric cardia invasion (p = 0.012). Total dissection of at least 20 lymph nodes was the minimal requirement to achieve accurate nodal staging.
CONCLUSIONS: Dissection of more than 20 lymph nodes is mandatory in TESCC patients to achieve accurate staging. Positive lymph node metastasis of 4 or higher is a significant independent prognostic factor.

Entities:  

Mesh:

Year:  2009        PMID: 19324127     DOI: 10.1016/j.athoracsur.2008.11.051

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  25 in total

1.  Invasion of a fundoplication sleeve by esophageal squamous-cell carcinoma.

Authors:  Vincent Zimmer; Jens Kraemer; Arno Buecker; Martin K Schilling; Frank Lammert; Markus Menges
Journal:  Gastrointest Cancer Res       Date:  2011-05

Review 2.  The significance of lymph node status as a prognostic factor for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

3.  Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.

Authors:  Jia Wang; Nan Wu; Qing-Feng Zheng; Shi Yan; Chao Lv; Shao-Lei Li; Yue Yang
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

4.  The revised American Joint Committee on Cancer staging system (7th edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma.

Authors:  Haris Zahoor; James D Luketich; Benny Weksler; Daniel G Winger; Neil A Christie; Ryan M Levy; Michael K Gibson; Jon M Davison; Katie S Nason
Journal:  Am J Surg       Date:  2015-06-26       Impact factor: 2.565

Review 5.  Nutrition therapy issues in esophageal cancer.

Authors:  Keith R Miller; Matthew C Bozeman
Journal:  Curr Gastroenterol Rep       Date:  2012-08

6.  Preoperative positron emission tomography/computed tomography predicts advanced lymph node metastasis in esophageal squamous cell carcinoma patients.

Authors:  Po-Kuei Hsu; Ko-Han Lin; Shyh-Jen Wang; Chien-Sheng Huang; Yu-Chung Wu; Wen-Hu Hsu
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

Review 7.  Lymph node dissection for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-26

8.  Clinical Significance of the Pre-therapeutic Nodal Size in Patients Undergoing Neo-Adjuvant Treatment Followed by Esophagectomy for Esophageal Squamous Cell Carcinoma.

Authors:  Shinji Mine; Masayuki Watanabe; Yu Imamura; Akihiko Okamura; Takanori Kurogochi; Takeshi Sano
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

9.  TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma.

Authors:  Po-Kuei Hsu; Hsuan-Yu Chen; Yi-Chen Yeh; Chueh-Chuan Yen; Yu-Chung Wu; Chung-Ping Hsu; Wen-Hu Hsu; Teh-Ying Chou
Journal:  J Gastroenterol       Date:  2013-08-21       Impact factor: 7.527

10.  Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy.

Authors:  Chen-Sung Lin; Chao-Yu Liu; Chih-Tao Cheng; Yu-Chen Tsai; Lun-Wei Chiou; Ming-Yuan Lee; Chia-Chuan Liu; Chih-Hsun Shih
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.